🇺🇸 FDA
Patent

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

granted A61KA61K38/1709A61K48/005

Quick answer

US patent 7105156 (Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells) held by The Regents of the University of California expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/1709, A61K48/005